THERAPY COMBINES HERPES AND MYCOPLASMA INFECTION IN WOMEN

Download full text PDF
Issue: 
2
Year: 
2015

Professor O. Gizinger (1), Biol. Dr., I. Kononova (2), Candidate of Medical Sciences, Professor O. Ziganshin (1), MD, Yu. Nefed'eva (1), Candidate of Medical Sciences 1 -South Ural State University, Chelyabinsk 2 -Ural State Medical University, Yekaterinburg

Clinical and immunological study of 70 women of reproductive age by herpes (HSV-2) infection and microplasma lower reproductive tract. For solution of tasks used a modern complex of clinical and laboratory methods, including the exploration of clinical, immunological, microbiological status of the genital tract of women. Genferon® drug use in complex therapy combined genital herpes and mycoplasma infection contributes to the normalization of the clinical picture, reducing the number of relapses, increase interrecurrent period, elimination of congenital dysfunction and adaptive immunity, identified in patients before treatment.

Keywords: 
urogenital infections
genital tract
mechanisms of immune protection
Genferon®



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Gizinger O.A. Vlijanie nizkointensivnogo lazernogo izluchenija na nejtrofily i faktory mukozal'nogo immuniteta. Dis. … d-ra biol. nauk. Cheljabinsk: Cheljabinskaja gosudarstvennaja meditsinskaja akademija, 2010.
  2. Gizinger O.A., Dolgushin I.I., Letjaeva O.I. Analiz pokazatelej fak-torov mukozal'nogo immuniteta repro-duktivnogo trakta zhenschin s hlamidij-noj infektsiej do i posle lokal'noj magnitolazernoj terapii // Voprosy kurortologii, fizioterapii i lecheb-noj fizicheskoj kul'tury. – 2010; 5: 30–3.
  3. Gizinger O.A., Dolgushin I.I. Sistema provospalitel'nyh tsitoki-nov v tservikal'nom sekrete u zhen-schin s urogenital'nym hlamidiozom // Tsitokiny i vospalenie. – 2006; 5 (4): 13.
  4. Dolgushin I.I., Gizinger O.A., Telesheva L.F. Immunologicheskie i mikrobiologicheskie aspekty dejstvija nizkointensivnogo lazera na faktory mestnogo immuniteta reproduktivnogo trakta zhenschin s hlamidijnoj infek-tsiej // Zhurn. mikrobiol., epidemiol. i immunol. – 2006; 4: 105–9.
  5. Dolgushin I.I., Gizinger O.A., Kolesnikov O.L. i dr. Vlijanie lazer-nogo izluchenija na nejtrofily tservikal'nogo sekreta pri urogenital'nom hlamidioze // Ros. zhurn. kozhn. i venerich. boleznej. – 2005; 1: 50–2.
  6. Gizinger O.A., Dolgushin I.I. Sistema provospalitel'nyh tsitokinov u zhenschin s urogenital'nym trihomoniazom // Med. immunol. – 2005; 7 (5–6): 601–4. Klinicheskie rekomendatsii. Vedenie bol'nyh infektsii peredavaemy mi polovym putem i urogenital'nymi infektsijami. Pod red. A.A. Kubanovoj / M.: Delovoj ekspress, 2013; 112 s.
  7. Ershov, F.I., Kiselev O.I. Interferony i ih induktory (ot molekul do lekarstv) / M.: GEOTAR-Media, 2005; 356 s.
  8. Molochkov V.A., Ivanov O.L., Chebotarev V.V. Urogenital'nye zaboleva nija, assotsiirovannye s genital'nymi mikoplazmami. Infektsii, peredavae-mye polovym putem: klinika, diagnostika, lechenie / M., 2006; 435–51.
  9. Fomicheva E.N., Zarubina E.N., Minaev V.I. i dr. Rol' ureaplazmennoj i hlamidijnoj infektsii v akusherskoj praktike // Akusherstvo i ginekolo-gija. – 2007; 2: 55–7.
  10. Haldin A.A., L'vov A.N., Markova Ju.A. i dr. Standartizatsija vedenija patsientov s retsidivirujuschim prostym gerpesom: terapija, profilaktika i konsul'tirovanie // Sovr. probl. dermatovenerol., immunol. i vracheb. kosme-tol. – 2010; 2: 59–65.
  11. Bouckenooghe T., Remacle C., Reusens B. Is taurine a functional nutrient? 12. // Curr. Opin. Clin. Nutr. Metab. Care. – 2006; 9 (6): 728–33.
  12. Viscardi R., Hasday J. Role of Ureaplasma species in neonatal chronic lung disease: epidemiologic and experimental evidence // Pediatr. Res. – 2009; 65 (5, Pt. 2): 84–90.
  13. Marcinkiewicz J., Kurnyta M., Biedron R. et al. Anti-inflammatory effects of 14. taurine derivatives (taurine chloramine, taurinebromamine, and taurolidine) are mediated by different mechanisms // Adv. Exp. Med. Biol. – 2006; 583: 481–92.